Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats

Ahmed ME, Khan MM, Javed H, Vaibhav K, Khan A, Tabassum R, Ashafaq M, Islam F, Safhi MM, Islam F (2013) Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type. Neurochem Int 62:492–501 Aloisi F (2001) Immune function of microglia. Glia 36:165–179 Blennow K, Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368:387–403 Chatterjee S, Mudher A (2018) Alzheimer’s disease and type 2 diabetes: A critical assessment of the shared pathological traits. Front Neurosci 12:383 Chételat G (2013) Alzheimer disease: Aβ-independent processes-rethinking preclinical AD. Nat Rev Neurol 9(3):123–124 Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10:264–273 Costa AP, Tramontina AC, Biasibetti R, Batassini C, Lopes MW, Wartchow KM (2012) Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia. Behav Brain Res 226(2):420–427 Csolle C, Sperlagh B (2010) Peripheral origin of IL-1β production in the rodent hippocampus under in vivo systemic bacterial lipoplysaccharide (LPS) challenge and it’s regulation by P2 × 7 receptors. J Neuroimmunol 219:38–46 Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SSV (2012) Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer’s disease in rats. J Mol Neurosci 46:223–235 Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138 Grieb P (2016) Intracerebroventricular streptozotocin injections as a model of Alzheimer’s disease: in search of a relevant mechanism. Mol Neurobiol 53:1741–1752 Gupta P, Sil S, Ghosh R, Ghosh A, Ghosh T (2018) Intracerebroventricular Aβ-induced neuroinflammation alters peripheral immune responses in rats. J Mol Neurosci 66: 572-586. https://doi.org/10.1007/s12031-018-1189-9 Halawany AME, Sayed NSE, Abdallah HM, Dine RSE (2017) Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer’s disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta-secretases and APH1a. Sci Rep 7:2902 Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Research 1281:117–127 Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS (2016) Streptozotocin intracerebroventricular-induced neurotoxicity and brain insulin resistance: a therapeutic intervention for treatment of sporadic Alzheimer’s Disease (sAD)-like pathology. Mol Neurobiol 53(7):4548–4562 Kraska A, Santin MD, Dorieux O, Joseph-Mathurin N, Bourrin E (2012) In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin. PLoS One 7(9):e46196 Lee Y, Kim YH, Park SJ, Huh JW, Kim SH, Kim SU, Kim JS, Jeong KJ (2014) Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer’s disease monkey model induced by intracerebroventricular injection of streptozotocin. J Alzheimer’s Dis 38:251–267 Lenzen S (2008) The mechanisms of alloxan- and streptozotocin induced diabetes. Diabetologia 51:216–226 Lewis C, Barbiers AR (1959) “Streptozotocin, a new antibiotic” In vitro and in vivo evaluation. Antibiot Annu 7:247–254 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275 Mizuno M, Yamada K, Olariu A, Nawa H, Nabeshima T (2000) Involvement of brainderived Neurotrophic factor in spatialmemory formation and maintenance in a radial arm maze test in rats. J Neurosci 20:7116–7121 Nakhate KT, Bharne AP, Verma VS, Aru DN, Kokare DM (2018) Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer’s disease via activation of Nrf2/ARE pathway and inhibition of β- secretase. Biomed Pharmacother 101:379–390 Nazem A, Sankowski R, Bacher M, Al-Abed Y (2015) Rodent models of neuroinflammation for Alzheimer’s disease. J Neuroinflammation 12:2–15 Neha, Sodhi RK, Jaggi AS, Singh N (2014) Animal models of dementia and cognitive dysfunction. Life Sci 109:73–86 Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, San Diego Prickaerts J, De Vente J, Honig W, Steinbusch H, Ittersum MMV, Blokland A, Steinbusch HW (2000) Nitric oxide synthase does not mediate neurotoxicity after an i.c.v. injection of streptozotocin in the rat. J Neural Transm 107:745–766 Rai S, Kamat PK, Nath C, Shukla R (2013) A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 254:1–9 Rajasekar N, Dwivedi S, Nath C (2014) Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin. Neuropharmacology 86:337–352 Reeta KH, Singh D, Gupta YK (2017) Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress cholinergic functions neuroinflammation. Neurochem Int 108:146–156 Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96:1005–1015 Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P (2013) What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research. J Neural Transm 120:233–252 Shingo AS, Kanabayashi T, Murase T, Kito S (2012) Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behav Brain Res 229:378–383 Sil S, Ghosh T (2016) Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer’s disease. J Neuroimmunol 291:115–124 Sil S, Ghosh R, Sanyal M, Guha D, Ghosh TK (2015) A comparison of neurodegeneration linked with neuroinflammation in brain areas of rats after intracerebroventricular colchicine injection. J Immunotoxicol 13:182–190 Singh A, Kumar A (2016) Comparative analysis of intrahippocampal amyloid beta (1–42) and it is intracerebroventricular streptozotocin models of Alzheimer’s Disease: Possible behavioral, biochemical,mitochondrial,cellular and histopathological evidences. J Alzheimers Dis Parkinsonism 6:208 Socci DJ, Bjugstad KB, Jones HC, Pattisapu JV, Arendash GW (1999) Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp Neurol 155:109–117 Sonkusare S, Srinivasan K, Kaul C, Ramarao P (2005) Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 77:1–14 Thorens B (2011) Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab (Suppl 1):82–88 Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, Morris JC, Raichle ME, Mintun MA (2010) Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proc Natl Acad Sci U S A 107(41):17763–17767